1-6 of 6
Takahiro Kobayashi
Close
Sort by
Journal Articles

ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone

Yasunori Kogure, Hiroshi Handa, Yuta Ito, Masaki Ri, Yuichi Horigome, Masaki Iino, Yoriko Harazaki, Takahiro Kobayashi, Masahiro Abe, Tadao Ishida, Shigeki Ito, Hiromi Iwasaki, Junya Kuroda, Hirohiko Shibayama, Kazutaka Sunami, Hiroyuki Takamatsu, Hideto Tamura, Toshiaki Hayashi, Kiwamu Akagi, Tomohiro Shinozaki, Takahiro Yoshida, Ikuo Mori, Shinsuke Iida, Takahiro Maeda, Keisuke Kataoka
Journal: Blood
Blood (2024) 143 (23): 2401–2413.
https://doi.org/10.1182/blood.2023022540
Published: 2024
Includes: Supplemental data
Journal Articles

Multiple Myeloma with 1q Gain/Amplification Shows Reduced CD38 Expression Via IL-6R Overexpression

Wataru Kuroki, Akihiro Kitadate, Masahiro Yamada, Sayaka Iwama, Yuto Takahashi, Yuki Fujioka, Takahiro Kobayashi, Sho Ikeda, Kentaro Narita, Kosei Matsue, Naoto Takahashi
Journal: Blood
Blood (2023) 142 (Supplement 1): 637.
https://doi.org/10.1182/blood-2023-173494
Published: 2023
Journal Articles

Hexokinase-2 Regulates Hypoxia-Inducible Autophagy, Leading to Enhance Anti-Apoptotic Capability of Refractory Multiple Myeloma

Sho Ikeda, MD PhD, Fumito Abe, MD PhD, Matsuda Yuka, Akihiro Kitadate, MD PhD, Takahiro Kobayashi, MD PhD, Naoto Takahashi, MD PhD, Hiroyuki Tagawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1787.
https://doi.org/10.1182/blood-2019-123360
Published: 2019
Journal Articles

Correlation between Changes in Granzyme B Expression and Time to Progression in Patients with Newly Diagnosed Multiple Myeloma Treated with Lenalidomide and Dexamethasone Therapy

Takahiro Kobayashi, MD PhD, Yuki Fujioka, MD PhD, Sho Ikeda, MD PhD, Hiroyoshi Nishikawa, MD PhD, Naoto Takahashi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1792.
https://doi.org/10.1182/blood-2019-125649
Published: 2019
Journal Articles

Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide

Takahiro Kobayashi, MD, Masatomo Miura, Takenori Niioka, Yuki Fujioka, Maiko Abumiya, Tomoko Yoshioka, Yoshihiro Kameoka, Hiroyoshi Nishikawa, Naoto Takahashi
Journal: Blood
Blood (2017) 130 (Supplement 1): 3846.
https://doi.org/10.1182/blood.V130.Suppl_1.3846.3846
Published: 2017
Journal Articles

Clarithromycin Elevates the Plasma Concentration of Lenalidomide Via Inhibition of MDR1

Naoki Takezako, MD PhD, Masatomo Miura, PhD, Akihisa Nagata, MD PhD, Naohiro Sekiguchi, MD PhD, Takenori Niioka, PhD, Seiji Shida, MD, Takahiro Kobayashi, MD, Maiko Abumiya, Akiyoshi Miwa, MD PhD, Naoto Takahashi, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3479.
https://doi.org/10.1182/blood.V124.21.3479.3479
Published: 2014